Recardio

About:

Recardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of cardiovascular diseases.

Website: http://www.recardio.eu

Description:

Recardio is a clinical-stage life science business focused on cardiovascular, cancer, and infectious disease medicines. The company focuses on developing regenerative therapeutic modalities that use a protein that is essential for cardiac regeneration, allowing patients with various cardiovascular diseases, such as acute myocardial infarction and chronic heart failure, to improve heart function, quality of life, and survival.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)recardio.eu

Founders:

Roman Schenk

Number of Employees:

11-50

Last Funding Date:

2015-11-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai